JFNNX Mutual Fund (Janus Henderson Global Life Sciences Fund Class N) is managed by Janus Henderson Investors. JFNNX expense ratio is 0.68%, holding 109 positions across sectors including Health Care, Unknown, Other. Inception date: 2018-01-26.

JFNNX performance shows a YTD return of 8.61%. The 1-year return is 39.65% and the 5-year return is 8.66%. JFNNX dividend yield stands at 4.29%, paid annually.

JFNNX top holdings include Eli Lilly And Company (9.7%), JOHNSON AND JOHNSON (5.6%), Astrazeneca Plc Adr (4.3%), Unitedhealth Group, Inc. (3.4%), Abbvie Inc Health Care (3.4%). View all JFNNX holdings, sector breakdown, or dividend history.

JFNNX can be compared against other funds using the overlap calculator or side-by-side comparison tool. JFNNX alternatives are available via the screener, along with tax-loss harvesting opportunities.